Theralase Technologies Inc.(TSXV:TLT) added to S&P/TSX Venture Composite Index
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.175 CAD | 0.00% | -2.78% | 0.00% |
07-08 | Theralase Technologies Inc. announced a financing transaction | CI |
06-20 | Theralase Technologies Inc. Announces Rutherrin Repurposes Non-Cancer Drugs for Cancer Therapy | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 31.04M | |
+2.67% | 852M | |
-34.22% | 197M | |
0.00% | 87.56M | |
-25.93% | 84.71M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Inc.(TSXV: TLT) added to S&P/TSX Venture Composite Index